KORU Medical Systems Inc (KRMD)

[Jlivermore29]

Craig Hallum note this morning. I am speculating here - Grifols announced some info on an Alzheimer's drug they are working on - Friday. Perhaps they mentioned the Xemblify launch (mentioned by CH below) during some type of call with analysts.

The below was posted on my micro cap club website a few hours ago.

Craig-Hallum Morning Call:
KRMD* – Management confirmed that Grifols has officially launched Xembify and began first patient dosing last week. Alex Nowak reminds investors that Xembify is the second drug approved that partnered using Koru's pump during clinical trials and Koru is now the premiere pump partner after approval (CSL Behring's Hizentra was the first). Alex states that Hizentra alone does ~$25M/year growing 20%+ and states Xembify + Hizentra could represent $50M in recurring annual revenue in 3 years. However, this does not include other new drug approvals, clinical trials or OUS sales (all of which started to benefit the model in 3Q19). Further, Alex only models Hizentra sales, meaning Xembify + others are all upside. Alex rates KRMD shares a Buy.